Kura Oncology, Inc.
KURA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$173,983 | -$152,631 | -$135,840 | -$130,466 |
| Dep. & Amort. | $848 | $849 | $759 | $558 |
| Deferred Tax | $0 | $0 | $0 | $4,603 |
| Stock-Based Comp. | $33,897 | $28,082 | $26,318 | $23,579 |
| Change in WC | $286,173 | $7,819 | -$2,982 | -$3,224 |
| Other Non-Cash | -$12,618 | -$8,943 | $1,683 | $399 |
| Operating Cash Flow | $134,317 | -$124,824 | -$110,062 | -$104,551 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$472 | -$168 | -$626 | -$1,147 |
| Net Acquisitions | $0 | $0 | -$33 | $126 |
| Inv. Purchases | -$659,048 | -$409,824 | -$270,655 | -$445,657 |
| Inv. Sales/Matur. | $557,930 | $425,549 | $303,908 | $319,969 |
| Other Inv. Act. | $0 | $0 | $33 | -$126 |
| Investing Cash Flow | -$101,590 | $15,557 | $32,627 | -$126,835 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $10,000 | -$7,250 |
| Stock Issued | $145,813 | $93,577 | $24,721 | $4,426 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $8,604 | $1,206 | $3,844 | -$611 |
| Financing Cash Flow | $154,417 | $94,783 | $38,565 | -$3,435 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $187,144 | -$14,484 | -$38,870 | -$234,821 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $37,318 | $51,802 | $90,882 | $325,703 |
| End Cash | $224,462 | $37,318 | $52,012 | $90,882 |
| Free Cash Flow | $133,845 | -$124,992 | -$110,688 | -$105,698 |